Andrew Oakley
Direktor/Vorstandsmitglied bei Novaremed AG
Profil
Andrew J.
Oakley is currently the Executive Director at Novaremed AG, Director at UNION Therapeutics A, and Director at Metys Pharmaceuticals AG.
He was previously the CFO, Secretary & Executive Director at Vectura Group Ltd., CFO, Secretary & Director at Vectura GmbH, Chief Financial Officer & Executive Vice President at Actelion Ltd., Chief Financial Officer & Executive Vice President at Sosei Group Corp., Chief Financial Officer at NovImmune SA, Member-Supervisory Board at Ventaleon GmbH, and Chief Financial Officer & Executive Vice President at Actelion Pharmaceuticals Ltd.
He is currently the Chief Financial Officer & Senior Vice President at Autolus Therapeutics Plc.
Mr. Oakley is a member of The Institute of Chartered Accountants in Australia and holds an undergraduate degree from Macquarie University and an MBA from London Business School.
Aktive Positionen von Andrew Oakley
| Unternehmen | Position | Beginn |
|---|---|---|
| The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | 21.05.2010 |
UNION Therapeutics A/S
 UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark. | Direktor/Vorstandsmitglied | - |
Novaremed AG
 Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Direktor/Vorstandsmitglied | - |
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andrew Oakley
| Unternehmen | Position | Ende |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Finanzdirektor/CFO | 31.03.2022 |
| NXERA PHARMA CO., LTD. | Finanzdirektor/CFO | 04.06.2018 |
| VECTURA GROUP | Finanzdirektor/CFO | 10.06.2016 |
| NOVIMMUNE SA | Finanzdirektor/CFO | 01.11.2014 |
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Finanzdirektor/CFO | 01.08.2013 |
Ausbildung von Andrew Oakley
| Macquarie University | Undergraduate Degree |
| London Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NXERA PHARMA CO., LTD. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
UNION Therapeutics A/S
UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark. | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
| The Institute of Chartered Accountants in Australia |
